Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Acute Effects of Sodium-glucose Cotransporter-2 Inhibition on Renal Oxygenation and Autonomic Function in Type 1 Diabetes

NCT04193566 is registered in ClinicalTrials.gov with Steno Diabetes Center Copenhagen as lead sponsor.

NCT NCT04193566
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04193566 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Acute Effects of Sodium-glucose Cotransporter-2 Inhibition on Renal Oxygenation and Autonomic Function in Type 1 Diabetes
Lead sponsor
Steno Diabetes Center Copenhagen
Phase
Phase 4
Overall status
Completed
Start date
February 1, 2020
Completion date
January 1, 2021
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autonomic neuropathy, diabetic, hypoxia, mitochondrial alteration, nephropathy, type 1 diabetes